These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12570693)

  • 21. Localization of type 1 17beta-hydroxysteroid dehydrogenase mRNA and protein in syncytiotrophoblasts and invasive cytotrophoblasts in the human term villi.
    Bonenfant M; Provost PR; Drolet R; Tremblay Y
    J Endocrinol; 2000 May; 165(2):217-22. PubMed ID: 10810285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase.
    Luu-The V
    J Steroid Biochem Mol Biol; 2001; 76(1-5):143-51. PubMed ID: 11384872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
    Brozic P; Lanisnik Risner T; Gobec S
    Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.
    Tremblay MR; Boivin RP; Luu-The V; Poirier D
    J Enzyme Inhib Med Chem; 2005 Apr; 20(2):153-63. PubMed ID: 15968820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey.
    Martel C; Melner MH; Gagné D; Simard J; Labrie F
    Mol Cell Endocrinol; 1994 Aug; 104(1):103-11. PubMed ID: 7821701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
    Poirier D
    Expert Opin Ther Pat; 2010 Sep; 20(9):1123-45. PubMed ID: 20645882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved homogeneous proximity-based screening assay of potential inhibitors of 17beta-hydroxysteroid dehydrogenases.
    Kokko L; Jaakohuhta S; Lindroos P; Soukka T
    Assay Drug Dev Technol; 2006 Dec; 4(6):671-8. PubMed ID: 17199505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
    Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
    Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women.
    Luu-The V; Dufort I; Pelletier G; Labrie F
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):77-82. PubMed ID: 11165014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Gingras S; Moriggl R; Groner B; Simard J
    Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
    Sang X; Han H; Li T; Lin SX
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases.
    Andersson S; Moghrabi N
    Steroids; 1997 Jan; 62(1):143-7. PubMed ID: 9029729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Butyl-N-methyl-11-(3'-hydroxy-21', 17'-carbolactone-19'-nor-17'alpha-pregna-1',3', 5'(10')-trien-7'alpha-yl)-undecanamide: an inhibitor of type 2 17beta-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity.
    Sam K; Labrie F; Poirier D
    Eur J Med Chem; 2000 Feb; 35(2):217-25. PubMed ID: 10758283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
    El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
    Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
    Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
    J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme.
    Mindnich R; Haller F; Halbach F; Moeller G; Hrabé de Angelis M; Adamski J
    J Mol Endocrinol; 2005 Oct; 35(2):305-16. PubMed ID: 16216911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12.
    Sakurai N; Miki Y; Suzuki T; Watanabe K; Narita T; Ando K; Yung TM; Aoki D; Sasano H; Handa H
    J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):174-81. PubMed ID: 16621523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation.
    Tremblay MR; Poirier D
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):179-91. PubMed ID: 9744515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.